Company BioLargo, Inc. OTC Bulletin Board
Equities
US09065A1007
Commodity Chemicals
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 14 | Transcript : BioLargo, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Odor-No-More Environmental
93.5
%
| 4 | 74.3 % | 11 | 93.5 % | +161.55% |
BioLargo Engineering, Science & Technologies
19.6
%
| 2 | 33.0 % | 2 | 19.6 % | +23.37% |
Intersegment
-13.5
%
| 0 | -8.4 % | -2 | -13.5 % | +234.75% |
BioLargo Canada
0.2
%
| 0 | 0.0 % | 0 | 0.2 % | +2,900.00% |
Clyra Medical
0.2
%
| 0 | 1.0 % | 0 | 0.2 % | -64.29% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 12 | 100.0 % | +107.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Charles Dargan
DFI | Director of Finance/CFO | 68 | 08-01-31 |
Chief Operating Officer | 55 | 02-05-31 | |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Mitch Noto
PRN | Corporate Officer/Principal | - | - |
Tonya Chandler
SAM | Sales & Marketing | - | - |
A. J. Sexton
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Marshall
BRD | Director/Board Member | 81 | 06-04-27 |
Kenneth Code
CTO | Chief Tech/Sci/R&D Officer | 77 | 07-03-31 |
Dennis Calvert
CEO | Chief Executive Officer | 61 | 02-05-31 |
Chief Operating Officer | 55 | 02-05-31 | |
Jack Strommen
BRD | Director/Board Member | 54 | 17-05-31 |
Linda Park
BRD | Director/Board Member | 46 | 22-10-31 |
Christina Bray
BRD | Director/Board Member | 36 | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 296,839,523 | 254,710,274 ( 85.81 %) | 0 | 85.81 % |
Company contact information
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+6.34% | 106B | |
-10.78% | 59.59B | |
+61.90% | 45.4B | |
+14.54% | 38.12B | |
+1.03% | 31.28B | |
+9.32% | 19.67B | |
+10.83% | 16.52B | |
+7.90% | 13.8B | |
-5.22% | 12.96B |
- Stock Market
- Equities
- BLGO Stock
- Stock
- Company BioLargo, Inc.